Features
Affluent Medical announces successful Artus implantation for UI treatment
Affluent Medical has announced the successful first-in-human implantation of Artus for the treatment of urinary incontinence in a patient as part of the European pilot study 'Dry'. Read more
Berry Global launches BerryHaler DPI
Berry Global has launched the BerryHaler, a dual chamber, dry powder inhaler (DPI) with a dose counter designed to provide better patient access to and support the effective delivery of combination drugs. Read more
Manchester University NHS Trust given £2.5m to investigate airway devices
Manchester University NHS Foundation Trust (MFT) has been awarded almost £2.5 million to investigate the effectiveness of new airways devices to transform care and outcomes for seriously ill patients in hospital Intensive Care Units (ICUs). Read more
FDA approves AGENT DCB for coronary artery disease patients
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. Read more
Biosense Webster receives CE mark for VARIPULSE PFA Platform
Biosense Webster, a cardiac arrhythmia treatment specialist and part of Johnson & Johnson MedTech, has received CE mark approval for the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation. Read more